| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Mar 02, 2023 | Mar 06, 2023 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $3.63 | $18,403 | -1.71% |
| Nov 16, 2022 | Nov 19, 2022 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $4.49 | $19,497 | -2.73% |
| Aug 16, 2022 | Aug 18, 2022 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $5.03 | $20,760 | -2.53% |
| May 17, 2022 | May 19, 2022 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $5.32 | $20,597 | -2.32% |
| Mar 01, 2022 | Mar 04, 2022 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $9.86 | $21,890 | -1.31% |
| Feb 10, 2022 | Feb 14, 2022 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $16 | $80,000 | -5.23% |
| Jan 03, 2022 | Jan 05, 2022 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $16.01 | $80,050 | -5.23% |
| Dec 01, 2021 | Dec 03, 2021 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $17.94 | $89,689 | -5.23% |
| Nov 16, 2021 | Nov 18, 2021 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $17.12 | $37,640 | -2.37% |
| Nov 02, 2021 | Nov 04, 2021 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $16.41 | $82,050 | -5.11% |
| Aug 17, 2021 | Aug 19, 2021 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $12.53 | $26,969 | -2.27% |
| May 18, 2021 | May 20, 2021 | Dupont Jakob EVP Head of R D | Sell | Atara Biotherapeutics, Inc. | ATRA | $14.55 | $75,427 | -5.18% |
| Dec 27, 2019 | Dec 31, 2019 | Dupont Jakob Chief Medical Officer | Sell | Gossamer Bio, Inc. | GOSS | $15.04 | $631,538 | -0 |
| Jan 11, 2016 | Jan 12, 2016 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $20.01 | $50,021 | -10.80% |
| Jan 06, 2016 | Jan 09, 2016 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $22.28 | $48,160 | -9.48% |
| Dec 10, 2015 | Dec 14, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $20.49 | $51,231 | -9.88% |
| Nov 10, 2015 | Nov 12, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $21.17 | $52,923 | -9.88% |
| Oct 26, 2015 | Oct 27, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $20 | $100,000 | -17.98% |
| Aug 10, 2015 | Aug 12, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $22.25 | $55,622 | -10.05% |
| Jul 10, 2015 | Jul 13, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $20.13 | $50,325 | -10.05% |
| Jul 06, 2015 | Jul 07, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $21.22 | $53,050 | -10.05% |
| Apr 10, 2015 | Apr 14, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $26.51 | $39,765 | -6.28% |
| Mar 10, 2015 | Mar 13, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $27.17 | $40,754 | -6.49% |
| Feb 10, 2015 | Feb 12, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $24.23 | $36,351 | -6.49% |
| Jan 12, 2015 | Jan 14, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $25.89 | $38,836 | -6.49% |
| Jan 05, 2015 | Jan 07, 2015 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $23 | $172,500 | -25.76% |
| Jul 23, 2014 | Jul 25, 2014 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $23 | $34,500 | -6.70% |
| Jun 26, 2014 | Jun 30, 2014 | Dupont Jakob SVP Chief Medical Officer | Sell | Oncomed Pharmaceuticals Inc | OMED | $23 | $34,503 | -6.70% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.